Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “antibiotics”

43 pharma patents match "antibiotics" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 43
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 43 pharmaceutical patents matching "antibiotics" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

43 results for “antibiotics” · 30,257 patents in full index Clear search

  1. US 12369604

    Methods of inhibition with microbial strains and antibiotics

    MICROBIAL DISCOVERY GROUP, LLC · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted

  2. US 12329747

    Use of lipophilic beta-lactam antibiotics and carboxylate esters for the treatment of bacterial infections within citrus and other plant species

    Board of Regents of the Nevada System of Higher Education on behalf of Nevada State College · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted

  3. US 11446279

    Aromatic 2-nitrosulfonyl fluoride antibiotics and methods of use thereof

    The Regents of the University of California · Granted Sep 20, 2022 · Expires Sep 15, 2042

    granted

  4. US 11298561

    Method of treating multi-drug resistance biofilm using targeted laser and antibiotics

    United States of America as represented by the Secretary of the Air Force · Granted Apr 12, 2022 · Expires Apr 7, 2042

    granted

  5. US 10953040

    Methods of treating bacterial infections with penam β-lactam antibiotics and branched poly(ethylenimine)

    The Board of Regents of the University of Oklahoma · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  6. US 10738093

    Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining

    China Ocean Mineral Resources R&D Association · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  7. US 10610601

    Polymeric antibiotics

    The Regents of the University of California · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  8. US 10434114

    Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics

    RedHill Biopharma Ltd. · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  9. US 10125167

    Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  10. US 10105379

    Pharmaceutical compositions comprising three antibiotics

    RedHill Biopharma Ltd. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  11. US 9889204

    Polymeric antibiotics

    The Regents of the University of California · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  12. US 9161990

    Hydrochloride salts of a glycopeptide-cephalosporin antbiotic compond

    THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  13. US 8933193

    Lantibiotics and uses thereof

    Regents of the University of Minnesota · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  14. US 8859506

    Glycopeptide phosphonate derivatives

    THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  15. US 8557978

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  16. US 8445632

    Selective poly-N-substituted glycine antibiotics

    The Regents of the University of California · Granted May 21, 2013 · Expires May 16, 2033

    granted

  17. US 8314217

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted

  18. US 8084417

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  19. US 8044195

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  20. US 7960505

    Lantibiotics and uses thereof

    Regents of the University of Minnesota · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  21. US 7728127

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  22. US 7713931

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted May 11, 2010 · Expires May 6, 2030

    granted

  23. US 7655621

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted

  24. US 7649080

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jan 19, 2010 · Expires Jan 14, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.